Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Tumor Load Matters – the Peritoneal Cancer Index in Patients With High-grade Serous Ovarian Cancer

EVA EGGER, FREYA MERKER, DAMIAN J. RALSER, MATEJA CONDIC, MILKA MARINOVA, MICHAEL MUDERS, MATTHIAS STOPE and ALEXANDER MUSTEA
Anticancer Research October 2022, 42 (10) 4825-4831; DOI: https://doi.org/10.21873/anticanres.15987
EVA EGGER
1Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: eva-katharina.egger@ukbonn.de
FREYA MERKER
1Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAMIAN J. RALSER
1Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MATEJA CONDIC
1Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MILKA MARINOVA
2Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHAEL MUDERS
3Department of Pathology, University Hospital Bonn, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MATTHIAS STOPE
1Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALEXANDER MUSTEA
1Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: The aim of this study was to analyze the predictive and prognostic value of the peritoneal cancer index (PCI) with regard to complete cytoreduction and clinical outcomes in patients with high-grade serous ovarian cancer. Patients and Methods: In a cohort comprising 188 patients with high-grade serous ovarian cancer, the PCI was retrospectively assessed. Clinical factors and perioperative complications were analyzed according to different PCI groups. Five-year disease-free survival (DFS) and overall survival (OS) were calculated based on the Kaplan-Meier Log rank analysis. Receiver operating characteristic (ROC) analysis was applied to detect associations of PCI and complete cytoreduction. Multivariate survival analysis was performed by Cox proportional hazards model. Results: In our study, the PCI was predictive of complete cytoreduction (ROC analysis; AUC 0.8227). In patients with optimal cytoreduction, higher PCI scores were associated with poorer 5-year OS (p<0.001) and 5-year DFS (p<0.001). Complications (G1-G5) were significantly more frequent in patients with PCI scores >9 (p=0.0023). Five-year OS was reduced in patients with severe complications compared to patients with none or mild complications (30.88% versus 51.01%; p=0.001). There were significant OS (p<0.001) and DFS (p<0.001) differences between patients with none or mild versus severe complications following complete cytoreduction within the PCI subgroups (PCI: 9-11, PCI: 12-18, PCI >18). Conclusion: The PCI score showed high predictability for complete cytoreduction and was associated with clinical outcomes. In presence of severe complications, higher PCI scores were associated with poorer survival. Hence, in patients with high tumor load, the prevention of severe perioperative complications is of utmost importance in all cases where complete cytoreduction is deemed to be feasible.

Key Words
  • Peritoneal cancer index
  • high grade ovarian cancer
  • cytoreduction
  • surgical complexity
  • Received June 5, 2022.
  • Revision received July 16, 2022.
  • Accepted August 9, 2022.
  • Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
View Full Text

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 42 (10)
Anticancer Research
Vol. 42, Issue 10
October 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tumor Load Matters – the Peritoneal Cancer Index in Patients With High-grade Serous Ovarian Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 13 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Tumor Load Matters – the Peritoneal Cancer Index in Patients With High-grade Serous Ovarian Cancer
EVA EGGER, FREYA MERKER, DAMIAN J. RALSER, MATEJA CONDIC, MILKA MARINOVA, MICHAEL MUDERS, MATTHIAS STOPE, ALEXANDER MUSTEA
Anticancer Research Oct 2022, 42 (10) 4825-4831; DOI: 10.21873/anticanres.15987

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Tumor Load Matters – the Peritoneal Cancer Index in Patients With High-grade Serous Ovarian Cancer
EVA EGGER, FREYA MERKER, DAMIAN J. RALSER, MATEJA CONDIC, MILKA MARINOVA, MICHAEL MUDERS, MATTHIAS STOPE, ALEXANDER MUSTEA
Anticancer Research Oct 2022, 42 (10) 4825-4831; DOI: 10.21873/anticanres.15987
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Feasibility of Computed Tomography-guided Percutaneous Renal Cryoablation Under Local Anesthesia: A Single Center Experience in Taiwan
  • Conversion Surgery for Unresectable Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel
  • Gastric Linitis Plastica: Clinical Characteristics and Outcomes from the National Cancer Database
Show more Clinical Studies

Similar Articles

Keywords

  • Peritoneal cancer index
  • high grade ovarian cancer
  • cytoreduction
  • surgical complexity
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire